Analystreport

Evolent Health, Inc. (NYSE: EVH) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $46.00 price target on the stock.

Evolent Health, Inc Class A  (EVH) 
Last evolent health, inc class a earnings: 2/25 04:02 pm Check Earnings Report
US:NYSE Investor Relations: ir.evolenthealth.com